InsidersTradesSigma
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Discover the full record of transactions filed by Wargacki Stephen. Officer active across 1 company, notably Aquestive Therapeutics, Inc.. Cumulatively, 6 reports have been published. Activity tracked since 9 March 2023. The latest transaction was disclosed on 7 March 2025 (Attribution). Regulator: SEC (Form 4). All data is free.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
6 of 6 declarations
Wargacki Stephen is Chief Science Officer at Aquestive Therapeutics, Inc. (XNAS). He has 6 filings in total, all for Aquestive Therapeutics, Inc., and the sampled recent filings cover the period from 2023-03-09 to 2025-03-11. In this recent sample, the modal transaction nature is Attribution, with individual amounts of EUR 86925.24536542718, EUR 50220.99923214555 and EUR 1485.465021305676.